Cargando…

Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report

BACKGROUND: Recent reports have raised serious concerns regarding acute myocarditis related to coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccines. There are only a few reports of fulminant lymphocytic myocarditis that developed after vaccination. Although the diagnostic approach varie...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Masayoshi, Toba, Takayoshi, Fukuyama, Yusuke, Tjan, Lidya Handayani, Mori, Yasuko, Hirata, Ken-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933941/
https://www.ncbi.nlm.nih.gov/pubmed/36819885
http://dx.doi.org/10.1093/ehjcr/ytad063
_version_ 1784889775095808000
author Fujii, Masayoshi
Toba, Takayoshi
Fukuyama, Yusuke
Tjan, Lidya Handayani
Mori, Yasuko
Hirata, Ken-ichi
author_facet Fujii, Masayoshi
Toba, Takayoshi
Fukuyama, Yusuke
Tjan, Lidya Handayani
Mori, Yasuko
Hirata, Ken-ichi
author_sort Fujii, Masayoshi
collection PubMed
description BACKGROUND: Recent reports have raised serious concerns regarding acute myocarditis related to coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccines. There are only a few reports of fulminant lymphocytic myocarditis that developed after vaccination. Although the diagnostic approach varied among them, no cases with multidisciplinary diagnostic approaches, including cytokine analysis, have been reported. CASE SUMMARY: A 59-year-old male with no medical history complained of chest pain a day after receiving the first dose of COVID-19 mRNA (BNT162b2) vaccination. On hospital Day 3, he developed a refractory cardiogenic shock and pulseless ventricular tachycardia, requiring mechanical circulatory support secondary to an exacerbation of myocarditis. Based on the clinical course and examination results, including histologic findings showing a diffuse lymphocytic inflammatory infiltrate with abundant T cells and macrophages in the myocardium, and cardiac magnetic resonance (CMR) findings showing a high-intensity signal on the T2-weighted image and late gadolinium enhancement, he was diagnosed with fulminant myocarditis related to COVID-19 mRNA vaccination. His haemodynamic status gradually improved without immunosuppressive or anti-inflammatory therapy, and he was discharged from hospital on Day 47. To investigate the pathogenesis, we performed cytokine analysis, which showed an increase in serum IP-10, MCP-3, and MIG concentrations, suggesting that Th1-type chemokines preferentially promote cellular immunity. DISCUSSION: In the present case of a patient with fulminant myocarditis following COVID-19 mRNA vaccination diagnosed through histopathological and CMR findings, additional cytokine analysis revealed that elevated levels of cytokines pertaining to Th1 immune response may be involved in disease pathogenesis. A multidisciplinary diagnostic approach is crucial not only to comprehend an individual patient’s condition but also to clarify the disease pathogenesis.
format Online
Article
Text
id pubmed-9933941
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-99339412023-02-17 Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report Fujii, Masayoshi Toba, Takayoshi Fukuyama, Yusuke Tjan, Lidya Handayani Mori, Yasuko Hirata, Ken-ichi Eur Heart J Case Rep Case Report BACKGROUND: Recent reports have raised serious concerns regarding acute myocarditis related to coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccines. There are only a few reports of fulminant lymphocytic myocarditis that developed after vaccination. Although the diagnostic approach varied among them, no cases with multidisciplinary diagnostic approaches, including cytokine analysis, have been reported. CASE SUMMARY: A 59-year-old male with no medical history complained of chest pain a day after receiving the first dose of COVID-19 mRNA (BNT162b2) vaccination. On hospital Day 3, he developed a refractory cardiogenic shock and pulseless ventricular tachycardia, requiring mechanical circulatory support secondary to an exacerbation of myocarditis. Based on the clinical course and examination results, including histologic findings showing a diffuse lymphocytic inflammatory infiltrate with abundant T cells and macrophages in the myocardium, and cardiac magnetic resonance (CMR) findings showing a high-intensity signal on the T2-weighted image and late gadolinium enhancement, he was diagnosed with fulminant myocarditis related to COVID-19 mRNA vaccination. His haemodynamic status gradually improved without immunosuppressive or anti-inflammatory therapy, and he was discharged from hospital on Day 47. To investigate the pathogenesis, we performed cytokine analysis, which showed an increase in serum IP-10, MCP-3, and MIG concentrations, suggesting that Th1-type chemokines preferentially promote cellular immunity. DISCUSSION: In the present case of a patient with fulminant myocarditis following COVID-19 mRNA vaccination diagnosed through histopathological and CMR findings, additional cytokine analysis revealed that elevated levels of cytokines pertaining to Th1 immune response may be involved in disease pathogenesis. A multidisciplinary diagnostic approach is crucial not only to comprehend an individual patient’s condition but also to clarify the disease pathogenesis. Oxford University Press 2023-02-04 /pmc/articles/PMC9933941/ /pubmed/36819885 http://dx.doi.org/10.1093/ehjcr/ytad063 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Fujii, Masayoshi
Toba, Takayoshi
Fukuyama, Yusuke
Tjan, Lidya Handayani
Mori, Yasuko
Hirata, Ken-ichi
Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
title Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
title_full Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
title_fullStr Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
title_full_unstemmed Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
title_short Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
title_sort multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger rna vaccines: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933941/
https://www.ncbi.nlm.nih.gov/pubmed/36819885
http://dx.doi.org/10.1093/ehjcr/ytad063
work_keys_str_mv AT fujiimasayoshi multidisciplinarydiagnosticapproachforfulminantmyocarditisrelatedtocoronavirusdisease2019messengerrnavaccinesacasereport
AT tobatakayoshi multidisciplinarydiagnosticapproachforfulminantmyocarditisrelatedtocoronavirusdisease2019messengerrnavaccinesacasereport
AT fukuyamayusuke multidisciplinarydiagnosticapproachforfulminantmyocarditisrelatedtocoronavirusdisease2019messengerrnavaccinesacasereport
AT tjanlidyahandayani multidisciplinarydiagnosticapproachforfulminantmyocarditisrelatedtocoronavirusdisease2019messengerrnavaccinesacasereport
AT moriyasuko multidisciplinarydiagnosticapproachforfulminantmyocarditisrelatedtocoronavirusdisease2019messengerrnavaccinesacasereport
AT hiratakenichi multidisciplinarydiagnosticapproachforfulminantmyocarditisrelatedtocoronavirusdisease2019messengerrnavaccinesacasereport